137 related articles for article (PubMed ID: 32941122)
1. Nonmuscle Myosin II Activation Regulates Cell Proliferation, Cell Contraction, and Myofibroblast Differentiation in Keloid-Derived Fibroblasts.
Lu YY; Fang CC; Hong CH; Wu CH; Lin YH; Chang KL; Lee CH
Adv Wound Care (New Rochelle); 2020 Sep; 9(9):491-501. PubMed ID: 32941122
[No Abstract] [Full Text] [Related]
2. Temporal spatial expression and function of non-muscle myosin II isoforms IIA and IIB in scar remodeling.
Bond JE; Ho TQ; Selim MA; Hunter CL; Bowers EV; Levinson H
Lab Invest; 2011 Apr; 91(4):499-508. PubMed ID: 21102503
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen Sulfide Suppresses Skin Fibroblast Proliferation
Li L; He Z; Zhu Y; Shen Q; Yang S; Cao S
Oxid Med Cell Longev; 2022; 2022():7434733. PubMed ID: 35774378
[TBL] [Abstract][Full Text] [Related]
4. Keloid Core Factor CTRP3 Overexpression Significantly Controlled TGF-
He L; Zhu C; Dou H; Yu X; Jia J; Shu M
Dis Markers; 2023; 2023():9638322. PubMed ID: 37091895
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-specific peptidase 11 promotes development of keloid derived fibroblasts by de-ubiquitinating TGF-β receptorII.
Li T; Huang J; Zeng A; Yu N; Long X
Burns; 2024 Apr; 50(3):641-652. PubMed ID: 38097445
[TBL] [Abstract][Full Text] [Related]
6. Mechanical and Thermodynamic Properties of Non-Muscle Contractile Tissues: The Myofibroblast and the Molecular Motor Non-Muscle Myosin Type IIA.
Lecarpentier Y; Claes V; Hébert JL; Schussler O; Vallée A
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299379
[TBL] [Abstract][Full Text] [Related]
7. Exclusive expression of KANK4 promotes myofibroblast mobility in keloid tissues.
Oishi M; Shinjo K; Takanari K; Muraoka A; Suzuki MM; Kanbe M; Higuchi S; Ebisawa K; Hashikawa K; Kamei Y; Kondo Y
Sci Rep; 2024 Apr; 14(1):8725. PubMed ID: 38622256
[TBL] [Abstract][Full Text] [Related]
8. Osteomodulin contributes to keloid development by regulating p38 MAPK signaling.
Li Q; Chen H; Liu Y; Bi J
J Dermatol; 2023 Jul; 50(7):895-905. PubMed ID: 37017425
[TBL] [Abstract][Full Text] [Related]
9. Insights into How Plant-Derived Extracts and Compounds Can Help in the Prevention and Treatment of Keloid Disease: Established and Emerging Therapeutic Targets.
Boo YC
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279232
[TBL] [Abstract][Full Text] [Related]
10. Role of ZIP kinase in development of myofibroblast differentiation from HPMCs.
Choo YY; Sakai T; Ikebe R; Jeffers A; Idell S; Tucker TA; Ikebe M
Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L353-L366. PubMed ID: 38252666
[TBL] [Abstract][Full Text] [Related]
11. Myofibroblasts Are Not Characteristic Features of Keloid Lesions.
Hahn JM; McFarland KL; Combs KA; Powell HM; Supp DM
Plast Reconstr Surg Glob Open; 2022 Nov; 10(11):e4680. PubMed ID: 36448015
[TBL] [Abstract][Full Text] [Related]
12. Tensile forces drive a reversible fibroblast-to-myofibroblast transition during tissue growth in engineered clefts.
Kollmannsberger P; Bidan CM; Dunlop JWC; Fratzl P; Vogel V
Sci Adv; 2018 Jan; 4(1):eaao4881. PubMed ID: 29349300
[TBL] [Abstract][Full Text] [Related]
13. The critical role of myosin IIA in platelet internal contraction.
Johnson GJ; Leis LA; Krumwiede MD; White JG
J Thromb Haemost; 2007 Jul; 5(7):1516-29. PubMed ID: 17488351
[TBL] [Abstract][Full Text] [Related]
14. PAX5 activates telomerase activity and proliferation in keloid fibroblasts by transcriptional regulation of SND1, thus promoting keloid growth in burn-injured skin.
Qin G; Sun Y; Guo Y; Song Y
Inflamm Res; 2021 Apr; 70(4):459-472. PubMed ID: 33616676
[TBL] [Abstract][Full Text] [Related]
15. TWEAK/Fn14 signaling may function as a reactive compensatory mechanism against extracellular matrix accumulation in keloid fibroblasts.
Zhang Y; Li X; Liu W; Hu G; Gu H; Cui X; Zhang D; Zeng W; Xia Y
Eur J Cell Biol; 2023 Jun; 102(2):151290. PubMed ID: 36709605
[TBL] [Abstract][Full Text] [Related]
16. The abnormal proplatelet formation in MYH9-related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition.
Chen Y; Boukour S; Milloud R; Favier R; Saposnik B; Schlegel N; Nurden A; Raslova H; Vainchenker W; Balland M; Nurden P; Debili N
J Thromb Haemost; 2013 Dec; 11(12):2163-75. PubMed ID: 24165359
[TBL] [Abstract][Full Text] [Related]
17. SPARC promotes fibroblast proliferation, migration, and collagen production in keloids by inactivation of p53.
Shi S; Li Q; Liu Y; Zhang R; Chen H
J Dermatol Sci; 2023 Jan; 109(1):2-11. PubMed ID: 36642579
[TBL] [Abstract][Full Text] [Related]
18. Skin fibrosis associated with keloid, scleroderma and Jorge Lobo's disease (lacaziosis): An immuno-histochemical study.
Tafuri WL; Tomokane TY; Silva AMG; Kanashiro-Galo L; Mosser DM; Quaresma JAS; Pagliari C; Sotto MN
Int J Exp Pathol; 2022 Dec; 103(6):234-244. PubMed ID: 36183172
[TBL] [Abstract][Full Text] [Related]
19. IGFBP-7 secreted by adipose-derived stem cells inhibits keloid formation via the BRAF/MEK/ERK signaling pathway.
Liu F; Yu T; Liu J; Yang Q; Wu J; Ren J; Zhu N
J Dermatol Sci; 2023 Jul; 111(1):10-19. PubMed ID: 37316358
[TBL] [Abstract][Full Text] [Related]
20. Keloid Disorder: Genetic Basis, Gene Expression Profiles, and Immunological Modulation of the Fibrotic Processes in the Skin.
Cohen AJ; Nikbakht N; Uitto J
Cold Spring Harb Perspect Biol; 2023 Jul; 15(7):. PubMed ID: 36411063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
